Evidence map›Paper›PMID 34632098›Full record

ArticleHealth science reports2021

Clinical experience with a new injectable hyaluronic acid designed to improve skin quality in a private clinic in Brazil: A retrospective cohort study.

Daniel Dal'Asta Coimbra

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Hyaluronic Acid ProfhiloMedicina (Kaunas, Lithuania) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Daniel Dal'Asta CoimbraInstituto de Dermatologia Professor Rubem David Azulay Santa Casa de Misericórdia/IDPRDA Rio de Janeiro Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJuvéderm Volite is a skin-conditioning hyaluronic acid (HA) gel for intradermal injection that provides longer-lasting effects with a lower concentration of hyaluronic acid. Few studies evaluating its use for aesthetic purposes are available.

aimTo examine the use and safety of Juvéderm Volite in daily clinical practice.

methodsA retrospective cohort study of subjects treated with Juvéderm Volite for aesthetic purposes from May 2018 to October 2019 in Rio de Janeiro. Data were extracted from the attending physician's records obtained at each medical appointment. Subjects were assessed according to their age group and treatment characteristics, which include the use of cannulas vs needles and the effectiveness and safety of associated treatments in a single session. Need for subsequent treatment was stratified by touch-up treatment (<3-month period) and repeat treatment (≥3-month period). Safety assessment was based on the report of nodule formation and late hypersensitivity in patients. Appropriate statistical tests were used for data analysis.

resultsOne hundred and eight subjects were included in the study analysis. The total number of treatment sessions consisted of 159, with a mean follow-up time of 300.3 days. Of the total 108 subjects, 8.4% required touch-up treatment for optimum correction and repeat treatment occurred in 9.0%. No cases of adverse events were reported during the follow-up period.

conclusionsThis study has shown, based on clinical observation, that Juvéderm Volite is a useful tool to improve skin quality, requiring fewer and less frequent maintenance treatments. No serious adverse events were reported during the follow-up period.

Indexed as

aestheticsdermal fillershyaluronic acidJuvéderm Voliteskin aging

Identifiers

PMID34632098
PMCPMC8493242
OpenAlexW3204434979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.